Growing community of inventors

Libertyville, IL, United States of America

Christin Tse

Average Co-Inventor Count = 6.10

ph-index = 2

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 33

Christin TseAlbert Lai (2 patents)Christin TseDimitri Semizarov (1 patent)Christin TseDavid W Morris (1 patent)Christin TseAli Fattaey (1 patent)Christin TseRobert Booher (1 patent)Christin TseMichael Rowe (1 patent)Christin TseMarc S Malandro (1 patent)Christin TseRichard R Lesniewski (1 patent)Christin TseEdward Moler (1 patent)Christin TseTamar Uziel (1 patent)Christin TseAbdallah Fanidi (1 patent)Christin TseXie Xu (1 patent)Christin TseDavid Ching Siang Huang (1 patent)Christin TseGuoying Yu (1 patent)Christin TseMark F Van Delft (1 patent)Christin TseChristin Tse (3 patents)Albert LaiAlbert Lai (3 patents)Dimitri SemizarovDimitri Semizarov (10 patents)David W MorrisDavid W Morris (9 patents)Ali FattaeyAli Fattaey (8 patents)Robert BooherRobert Booher (5 patents)Michael RoweMichael Rowe (3 patents)Marc S MalandroMarc S Malandro (3 patents)Richard R LesniewskiRichard R Lesniewski (2 patents)Edward MolerEdward Moler (2 patents)Tamar UzielTamar Uziel (1 patent)Abdallah FanidiAbdallah Fanidi (1 patent)Xie XuXie Xu (1 patent)David Ching Siang HuangDavid Ching Siang Huang (1 patent)Guoying YuGuoying Yu (1 patent)Mark F Van DelftMark F Van Delft (1 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Sagres Discovery, Inc. (2 from 9 patents)

2. Abbvie Inc. (1 from 822 patents)

3. Novartis Vaccines & Diagnostics, Gmbh (1 from 245 patents)


3 patents:

1. 9045800 - Methods and compositions for identifying, classifying and monitoring subject having Bcl-2 family inhibitor-resistant tumors and cancers

2. 7919246 - SEMA4D in cancer diagnosis, detection and treatment

3. 7332281 - Therapeutic targets in cancer

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
12/12/2025
Loading…